Global incidence and prevalence of nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compar...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Clinical and molecular hepatology Ročník 29; číslo Suppl; s. S32 - S42
Hlavní autori: Teng, Margaret LP, Ng, Cheng Han, Huang, Daniel Q., Chan, Kai En, Tan, Darren JH, Lim, Wen Hui, Yang, Ju Dong, Tan, Eunice, Muthiah, Mark D.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Korea (South) Korean Association for the Study of the Liver 01.02.2023
The Korean Association for the Study of the Liver
Predmet:
Adult
Diabetes
epidemiology
Fatty liver
Female
Humans
Incidence
Liver diseases
Male
Meta-analysis
Metabolism
Non-alcoholic Fatty Liver Disease - diagnosis
Non-alcoholic Fatty Liver Disease - epidemiology
nonalcoholic fatty liver disease
Obesity
Obesity - complications
Obesity - epidemiology
Prevalence
Review
South America
United States > US
Japan
Europe
Egypt
Africa
North America
Oceania
Middle East
Southeast Asia
South Korea
Iran
Asia
China
Taiwan
Hong Kong China
Israel
Mediterranean Area
Nonalcoholic fatty liver disease
Prevalence
Epidemiology
Incidence
ISSN:2287-2728, 2287-285X, 2287-285X
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Editor: Sang Gyune Kim, Soonchunhyang University Hospital Bucheon, Korea
Margaret LP Teng and Cheng Han Ng contributed equally as co-first authors.
ISSN:2287-2728
2287-285X
2287-285X
DOI:10.3350/cmh.2022.0365